- Home
- IMTX vs AHCO Comparison
IMTX vs AHCO Comparison
Compare IMTX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTX | AHCO |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMTX | AHCO |
|---|---|---|
| Price | $10.34 | $10.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.25 | $13.60 |
| AVG Volume (30 Days) | 623.6K | ★ 1.2M |
| Earning Date | 11-17-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.55 |
| Revenue | $99,445,031.00 | ★ $3,255,213,000.00 |
| Revenue This Year | N/A | $1.07 |
| Revenue Next Year | $24.39 | $6.49 |
| P/E Ratio | ★ N/A | $18.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.30 | $7.11 |
| 52 Week High | $12.41 | $11.63 |
Technical Indicators
Market Signals| Indicator | IMTX | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 60.19 |
| Support Level | $9.52 | $9.92 |
| Resistance Level | $10.24 | $10.62 |
| Average True Range (ATR) | 0.68 | 0.36 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 28.72 | 81.55 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.